ROCKVILLE, Md.--(BUSINESS WIRE)--Jan. 25, 2006--Celera Genomics Group (NYSE:CRA), an Applera Corporation business, today reported a net loss of $17.3 million, or $0.23 per share, for the second quarter of fiscal 2006 ended December 31, 2005, compared to a net loss of $19.4 million, or $0.27 per share, for the second quarter of fiscal 2005. All per share amounts refer to Applera Corporation-Celera Genomics Group Common Stock.
